HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Persistent pituitary resistance to thyroid hormone in congenital versus later-onset hypothyroidism.

Abstract
The pituitary and peripheral responses to L-T4 and L-T3 therapy were studied in 12 patients with congenital goitrous hypothyroidism, in 10 patients with an ectopic thyroid and onset of hypothyroidism at 3-8 years of age, and in 6 patients with adult-onset hypothyroidism, after they had had their chronic thyroid hormone replacement therapy discontinued for 30 days. They were first treated with increasing L-T4 (0.1, 0.2 and 0.4 mg daily) followed by L-T3 (0.05 and 0.2 mg daily) after stopping thyroid medication for another month. Ten normal subjects were treated identically. In normal individuals the peak TSH, alpha, and TSH-beta response to TRH was significantly decreased with 0.1 mg L-T4 or 0.05 mg L-T3 daily and was suppressed with 0.2 and 0.4 mg L-T4 or 0.2 mg L-T3 daily; serum cholesterol and triglyceride decreased significantly with 0.2 or 0.4 mg L-T4 or 0.2 mg L-T3 daily; testosterone-estradiol binding globulin (TeBG) increased significantly at the same doses. In congenitally hypothyroid patients receiving 0.2 mg L-T4 daily, the mean peak TSH after TRH was 24 +/- 17 microU/ml, whereas in patients with an ectopic thyroid or adult-onset hypothyroidism the peak TSH was significantly less at 5.9 +/- 8.8 and 5.5 +/- 5.7 microU/ml, respectively. Only at the highest doses of L-T4 (0.4 mg/day) or L-T3 (0.2 mg/day) was the TSH response to TRH suppressed in the congenitally hypothyroid group. The alpha and TSH-beta subunit levels followed those of TSH.(ABSTRACT TRUNCATED AT 250 WORDS)
AuthorsH Cavaliere, G A Medeiros-Neto, W Rosner, I A Kourides
JournalJournal of endocrinological investigation (J Endocrinol Invest) Vol. 8 Issue 6 Pg. 527-32 (Dec 1985) ISSN: 0391-4097 [Print] Italy
PMID3938790 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Sex Hormone-Binding Globulin
  • Thyroid Hormones
  • Triglycerides
  • Triiodothyronine
  • Thyrotropin-Releasing Hormone
  • Thyrotropin
  • Cholesterol
  • Thyroxine
Topics
  • Adolescent
  • Adult
  • Child
  • Cholesterol (blood)
  • Congenital Hypothyroidism
  • Drug Resistance
  • Female
  • Humans
  • Hypothyroidism (blood, drug therapy)
  • Male
  • Pituitary Gland (drug effects)
  • Sex Hormone-Binding Globulin (metabolism)
  • Thyroid Hormones (therapeutic use)
  • Thyrotropin (blood)
  • Thyrotropin-Releasing Hormone
  • Thyroxine (therapeutic use)
  • Triglycerides (blood)
  • Triiodothyronine (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: